A clinical and proteomics approach to predict the presence of obstructive peripheral arterial disease: From the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) Study

Peripheral arterial disease (PAD) is a global health problem that is frequently underdiagnosed and undertreated. Noninvasive tools to predict the presence and severity of PAD have limitations including inaccuracy, cost, or need for intravenous contrast and ionizing radiation.

• Publication year

  2018

• Venue

  Clinical Cardiology

• Publication date

  2018-06-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/clc.22939PMID 29876944PMCID PMC6489776
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Follicle-Stimulating Hormone Levels and Subclinical Atherosclerosis in Older Postmenopausal Women

  2018cited by this paper
• A clinical and proteomics approach to predict the presence of obstructive peripheral arterial disease: From the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) Study

  2018cited by this paper
• Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

  2017cited by this paper
• A Clinical and Biomarker Scoring System to Predict the Presence of Obstructive Coronary Artery Disease.

  2017cited by this paper
• Usefulness of Multiple Biomarkers for Predicting Incident Major Adverse Cardiac Events in Patients Who Underwent Diagnostic Coronary Angiography (from the Catheter Sampled Blood Archive in Cardiovascular Diseases [CASABLANCA] Study).

  2017cited by this paper
• Follicle‐Stimulating Hormone, Its Association with Cardiometabolic Risk Factors, and 10‐Year Risk of Cardiovascular Disease in Postmenopausal Women

  2017cited by this paper
• Geographic variation and risk factors for systemic and limb ischemic events in patients with symptomatic peripheral artery disease: Insights from the REACH Registry

  2017cited by this paper
• Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

  2017cited by this paper
• Midkine, a heparin-binding growth factor, and its roles in atherogenesis and inflammatory kidney diseases.

  2016cited by this paper
• Interleukin 23 Levels Are Increased in Carotid Atherosclerosis: Possible Role for the Interleukin 23/Interleukin 17 Axis

  2015cited by this paper
• Serum levels for midkine, a heparin-binding growth factor, inversely correlate with angiotensin and endothelin receptor autoantibody titers in patients with macroangiopathy.

  2014cited by this paper
• Design, methods, baseline characteristics and interim results of the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) study

  2014influential reference
• Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis.

  2013cited by this paper
• Expression of midkine, a multifunctional cytokine, in human atherosclerotic plaques

  2013cited by this paper
• Interleukin-23 serum levels in patients affected by peripheral arterial disease.

  2012cited by this paper
• An evidence-based score to detect prevalent peripheral artery disease (PAD)

  2012cited by this paper
• Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability

  2010cited by this paper
• 双対平坦空間におけるLeast Angle Regressionと情報量規準

  2009cited by this paper
• The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects.

  2008cited by this paper
• Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease.

  2006cited by this paper
• Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention.

  2004cited by this paper
• The intra- and interobserver variability of ankle-arm blood pressure index according to its mode of calculation.

  2003cited by this paper
• Peripheral arterial disease detection, awareness, and treatment in primary care.

  2001cited by this paper
• Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care

  2001cited by this paper
• Overexpression of Eotaxin and the CCR3 Receptor in Human Atherosclerosis: Using Genomic Technology to Identify a Potential Novel Pathway of Vascular Inflammation

  2000cited by this paper
• Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis.

  1996cited by this paper

• Artificial Intelligence Techniques for Prognostic and Diagnostic Assessments in Peripheral Artery Disease: A Scoping Review

  2025influential citation
• Diagnosis models to predict peripheral arterial disease: a systematic review and meta analysis

  2025cites this paper
• A validated multivariable machine learning model to predict cardio-kidney risk in diabetic kidney disease

  2025cites this paper
• Artificial Intelligence in Vascular Diseases: From Clinical Practice to Medical Research and Education.

  2025cites this paper
• CCL11 (Eotaxin) Promotes the Advancement of Aging-Related Cardiovascular Diseases

  2025cites this paper
• Identification of Inflammatory Biomarkers for Predicting Peripheral Arterial Disease Prognosis in Patients with Diabetes

  2024cites this paper
• Associations between lipoprotein(a), oxidized phospholipids, and extracoronary vascular disease

  2024cites this paper
• Unsupervised classification of multi-contrast magnetic resonance histology of peripheral arterial disease lesions using a convolutional variational autoencoder with a Gaussian mixture model in latent space: A technical feasibility study

  2024cites this paper
• Machine Learning in Vascular Medicine: Optimizing Clinical Strategies for Peripheral Artery Disease

  2024cites this paper
• Current Applications and Future Perspectives of Artificial and Biomimetic Intelligence in Vascular Surgery and Peripheral Artery Disease

  2024cites this paper
• Support Vector Machine for Cardiac Catheterization

  2023cites this paper
• Artificial intelligence in atherosclerotic disease: Applications and trends

  2023cites this paper
• Applications of artificial intelligence for patients with peripheral artery disease.

  2022cites this paper
• The Ability of Clinical Decision Rules to Detect Peripheral Arterial Disease: A Narrative Review

  2022cites this paper
• The Role of Circulating Biomarkers in Peripheral Arterial Disease

  2021cites this paper
• Machine learning in vascular surgery: a systematic review and critical appraisal

  2021cites this paper
• Untangling Myocardial Injury: Moving From Consequence to Cause.

  2021cites this paper
• Leveraging Machine Learning and Artificial Intelligence to Improve Peripheral Artery Disease Detection, Treatment, and Outcomes.

  2021cites this paper
• Gaining Efficiency in Clinical Trials With Cardiac Biomarkers: JACC Review Topic of the Week.

  2021cites this paper
• Role of Neuronal Nitric Oxide Synthase on Cardiovascular Functions in Physiological and Pathophysiological States.

  2020cites this paper
• Improving the Detection of Acute Coronary Syndrome Using Machine Learning of Blood Biomarkers

  2020cites this paper
• Study of three novel biomarkers, MR-proADM, midkine, and stromelysin2, and peripheral atherosclerosis in a Chinese Han population: A case-control study

  2020cites this paper
• Performance of a clinical/proteomic panel to predict obstructive peripheral artery disease in patients with and without diabetes mellitus

  2019influential citation
• A clinical and proteomics approach to predict the presence of obstructive peripheral arterial disease: From the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) Study

  2018cites this paper
• Follicle-Stimulating Hormone Levels and Subclinical Atherosclerosis in Older Postmenopausal Women

  2018cites this paper